{"transactions":[{"id":1926597,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":95752,"kind":"person","name":"Slootweg Hugo Alexander","position":1,"cik":"0001744922","reported_name":"Slootweg Hugo Alexander","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-04-05T00:04:24.000Z","date":"2023-04-01","kind":"grant","planned":false,"acquired":true,"shares":25200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest entirely on April 1, 2024."}],"balance_after":25200,"derivative":{"exercise_price":17.66,"expiration_date":"2033-04-01","underlying":"Common Stock","underlying_shares":25200},"source":{"system":"sec-edgar","filing":"0001104659-23-041736","document":"tm2311410-15_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465923041736/tm2311410-15_4seq1.xml","form_type":"4"}},{"id":2303342,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":95752,"kind":"person","name":"Slootweg Hugo Alexander","position":1,"cik":"0001744922","reported_name":"Slootweg Hugo Alexander","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-04-05T20:10:25.000Z","date":"2022-04-01","kind":"grant","acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest entirely on April 1, 2023."}],"balance_after":16500,"derivative":{"exercise_price":18.26,"expiration_date":"2032-04-01","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001104659-22-042752","document":"tm2211665-12_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465922042752/tm2211665-12_4seq1.xml","form_type":"4"}},{"id":2756562,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":95752,"kind":"person","name":"Slootweg Hugo Alexander","position":1,"cik":"0001744922","reported_name":"Slootweg Hugo Alexander","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-04-06T00:12:30.000Z","date":"2021-04-01","kind":"grant","acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest entirely on April 1, 2022."}],"balance_after":16500,"derivative":{"exercise_price":31.58,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001104659-21-046721","document":"tm2112099-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465921046721/tm2112099-3_4seq1.xml","form_type":"4"}},{"id":3185691,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":95752,"kind":"person","name":"Slootweg Hugo Alexander","position":1,"cik":"0001744922","reported_name":"Slootweg Hugo Alexander","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-04-02T20:33:33.000Z","date":"2020-04-01","kind":"grant","acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest entirely on April 1, 2021."}],"balance_after":16500,"derivative":{"exercise_price":9.78,"expiration_date":"2030-04-01","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001104659-20-042507","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465920042507/a4.xml","form_type":"4"}},{"id":3563695,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":95752,"kind":"person","name":"Slootweg Hugo Alexander","position":1,"cik":"0001744922","reported_name":"Slootweg Hugo Alexander","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-04-03T21:44:08.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":13500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest entirely on April 1, 2020."}],"balance_after":13500,"derivative":{"exercise_price":15.5,"expiration_date":"2029-04-01","underlying":"Common Stock","underlying_shares":13500},"source":{"system":"sec-edgar","filing":"0001104659-19-019727","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465919019727/a4.xml","form_type":"4"}},{"id":3860630,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":95752,"kind":"person","name":"Slootweg Hugo Alexander","position":1,"cik":"0001744922","reported_name":"Slootweg Hugo Alexander","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-07-26T21:26:02.000Z","date":"2018-07-24","kind":"grant","acquired":true,"shares":13500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted on July 19, 2018 subject to the completion of the Issuer's initial public offering, which closed on July 24, 2018. 25% of the shares underlying this stock option vest on July 19, 2019 and the remainder of the shares underlying this stock option vest in 24 equal monthly installments thereafter."}],"balance_after":13500,"derivative":{"exercise_price":15,"expiration_date":"2028-07-19","underlying":"Common Stock","underlying_shares":13500},"source":{"system":"sec-edgar","filing":"0001104659-18-047460","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465918047460/a4.xml","form_type":"4"}},{"id":3860629,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":95752,"kind":"person","name":"Slootweg Hugo Alexander","position":1,"cik":"0001744922","reported_name":"Slootweg Hugo Alexander","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2018-07-26T21:26:02.000Z","date":"2018-07-24","kind":"exercise","acquired":false,"shares":1013547,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"In connection with the completion of the Issuer's initial public offering, each share of the Issuer's series seed convertible preferred stock, series A convertible preferred stock and series B convertible preferred stock (collectively, the \"Preferred Stock\") converted into shares of the Issuer's common stock on a 1-for-9.94688 basis without payment or consideration. The Preferred Stock had no expiration date."},{"field":"shares","element":"transactionShares","label":"F4","text":"Reflects the number of shares of the applicable series of preferred stock held by the Reporting Person on an as-converted to common stock basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In connection with the completion of the Issuer's initial public offering, each share of the Issuer's series seed convertible preferred stock, series A convertible preferred stock and series B convertible preferred stock (collectively, the \"Preferred Stock\") converted into shares of the Issuer's common stock on a 1-for-9.94688 basis without payment or consideration. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"In connection with the completion of the Issuer's initial public offering, each share of the Issuer's series seed convertible preferred stock, series A convertible preferred stock and series B convertible preferred stock (collectively, the \"Preferred Stock\") converted into shares of the Issuer's common stock on a 1-for-9.94688 basis without payment or consideration. The Preferred Stock had no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"Reflects the number of shares of the applicable series of preferred stock held by the Reporting Person on an as-converted to common stock basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held directly by Forbion Capital Fund III Cooperatief U.A (\"Forbion Coop\"). Forbion III Management B.V. (\"Forbion Management\") is the director of Forbion Coop. The Reporting Person serves as one of the directors of Forbion Management and disclaims beneficial ownership over all shares of the Issuer for which Forbion Management may be deemed to beneficially own, except to the extent of his pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1013547},"source":{"system":"sec-edgar","filing":"0001104659-18-047460","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465918047460/a4.xml","form_type":"4"}},{"id":3860628,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":95752,"kind":"person","name":"Slootweg Hugo Alexander","position":1,"cik":"0001744922","reported_name":"Slootweg Hugo Alexander","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2018-07-26T21:26:02.000Z","date":"2018-07-24","kind":"exercise","acquired":false,"shares":2579881,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"In connection with the completion of the Issuer's initial public offering, each share of the Issuer's series seed convertible preferred stock, series A convertible preferred stock and series B convertible preferred stock (collectively, the \"Preferred Stock\") converted into shares of the Issuer's common stock on a 1-for-9.94688 basis without payment or consideration. The Preferred Stock had no expiration date."},{"field":"shares","element":"transactionShares","label":"F4","text":"Reflects the number of shares of the applicable series of preferred stock held by the Reporting Person on an as-converted to common stock basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In connection with the completion of the Issuer's initial public offering, each share of the Issuer's series seed convertible preferred stock, series A convertible preferred stock and series B convertible preferred stock (collectively, the \"Preferred Stock\") converted into shares of the Issuer's common stock on a 1-for-9.94688 basis without payment or consideration. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"In connection with the completion of the Issuer's initial public offering, each share of the Issuer's series seed convertible preferred stock, series A convertible preferred stock and series B convertible preferred stock (collectively, the \"Preferred Stock\") converted into shares of the Issuer's common stock on a 1-for-9.94688 basis without payment or consideration. The Preferred Stock had no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"Reflects the number of shares of the applicable series of preferred stock held by the Reporting Person on an as-converted to common stock basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held directly by Forbion Capital Fund III Cooperatief U.A (\"Forbion Coop\"). Forbion III Management B.V. (\"Forbion Management\") is the director of Forbion Coop. The Reporting Person serves as one of the directors of Forbion Management and disclaims beneficial ownership over all shares of the Issuer for which Forbion Management may be deemed to beneficially own, except to the extent of his pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2579881},"source":{"system":"sec-edgar","filing":"0001104659-18-047460","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465918047460/a4.xml","form_type":"4"}},{"id":3860627,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":95752,"kind":"person","name":"Slootweg Hugo Alexander","position":1,"cik":"0001744922","reported_name":"Slootweg Hugo Alexander","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series Seed Convertible Preferred Stock","published_at":"2018-07-26T21:26:02.000Z","date":"2018-07-24","kind":"exercise","acquired":false,"shares":994688,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"In connection with the completion of the Issuer's initial public offering, each share of the Issuer's series seed convertible preferred stock, series A convertible preferred stock and series B convertible preferred stock (collectively, the \"Preferred Stock\") converted into shares of the Issuer's common stock on a 1-for-9.94688 basis without payment or consideration. The Preferred Stock had no expiration date."},{"field":"shares","element":"transactionShares","label":"F4","text":"Reflects the number of shares of the applicable series of preferred stock held by the Reporting Person on an as-converted to common stock basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In connection with the completion of the Issuer's initial public offering, each share of the Issuer's series seed convertible preferred stock, series A convertible preferred stock and series B convertible preferred stock (collectively, the \"Preferred Stock\") converted into shares of the Issuer's common stock on a 1-for-9.94688 basis without payment or consideration. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"In connection with the completion of the Issuer's initial public offering, each share of the Issuer's series seed convertible preferred stock, series A convertible preferred stock and series B convertible preferred stock (collectively, the \"Preferred Stock\") converted into shares of the Issuer's common stock on a 1-for-9.94688 basis without payment or consideration. The Preferred Stock had no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"Reflects the number of shares of the applicable series of preferred stock held by the Reporting Person on an as-converted to common stock basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held directly by Forbion Capital Fund III Cooperatief U.A (\"Forbion Coop\"). Forbion III Management B.V. (\"Forbion Management\") is the director of Forbion Coop. The Reporting Person serves as one of the directors of Forbion Management and disclaims beneficial ownership over all shares of the Issuer for which Forbion Management may be deemed to beneficially own, except to the extent of his pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":994688},"source":{"system":"sec-edgar","filing":"0001104659-18-047460","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465918047460/a4.xml","form_type":"4"}},{"id":3860626,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":95752,"kind":"person","name":"Slootweg Hugo Alexander","position":1,"cik":"0001744922","reported_name":"Slootweg Hugo Alexander","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2018-07-26T21:26:02.000Z","date":"2018-07-24","kind":"exercise","acquired":false,"shares":248672,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Reflects warrants to acquire shares of the Issuer's Series Seed Convertible Preferred Stock which automatically converted into warrants to acquire shares of the Issuer's common stock immediately prior to the completion of the Issuer's initial public offering on a 1-for-9.94688 basis without payment or consideration. The warrants have no expiration date. The exercise price is $1.01 per share of the issuer's common stock."},{"field":"shares","element":"transactionShares","label":"F4","text":"Reflects the number of shares of the applicable series of preferred stock held by the Reporting Person on an as-converted to common stock basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Reflects warrants to acquire shares of the Issuer's Series Seed Convertible Preferred Stock which automatically converted into warrants to acquire shares of the Issuer's common stock immediately prior to the completion of the Issuer's initial public offering on a 1-for-9.94688 basis without payment or consideration. The warrants have no expiration date. The exercise price is $1.01 per share of the issuer's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Reflects warrants to acquire shares of the Issuer's Series Seed Convertible Preferred Stock which automatically converted into warrants to acquire shares of the Issuer's common stock immediately prior to the completion of the Issuer's initial public offering on a 1-for-9.94688 basis without payment or consideration. The warrants have no expiration date. The exercise price is $1.01 per share of the issuer's common stock."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"Reflects the number of shares of the applicable series of preferred stock held by the Reporting Person on an as-converted to common stock basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held directly by Forbion Capital Fund III Cooperatief U.A (\"Forbion Coop\"). Forbion III Management B.V. (\"Forbion Management\") is the director of Forbion Coop. The Reporting Person serves as one of the directors of Forbion Management and disclaims beneficial ownership over all shares of the Issuer for which Forbion Management may be deemed to beneficially own, except to the extent of his pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Series Seed Convertible Preferred Stock","underlying_shares":248672},"source":{"system":"sec-edgar","filing":"0001104659-18-047460","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465918047460/a4.xml","form_type":"4"}},{"id":3860625,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":95752,"kind":"person","name":"Slootweg Hugo Alexander","position":1,"cik":"0001744922","reported_name":"Slootweg Hugo Alexander","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2018-07-26T21:26:02.000Z","date":"2018-07-24","kind":"exercise","acquired":true,"shares":248672,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Reflects warrants to acquire shares of the Issuer's Series Seed Convertible Preferred Stock which automatically converted into warrants to acquire shares of the Issuer's common stock immediately prior to the completion of the Issuer's initial public offering on a 1-for-9.94688 basis without payment or consideration. The warrants have no expiration date. The exercise price is $1.01 per share of the issuer's common stock."},{"field":"shares","element":"transactionShares","label":"F4","text":"Reflects the number of shares of the applicable series of preferred stock held by the Reporting Person on an as-converted to common stock basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Reflects warrants to acquire shares of the Issuer's Series Seed Convertible Preferred Stock which automatically converted into warrants to acquire shares of the Issuer's common stock immediately prior to the completion of the Issuer's initial public offering on a 1-for-9.94688 basis without payment or consideration. The warrants have no expiration date. The exercise price is $1.01 per share of the issuer's common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Reflects warrants to acquire shares of the Issuer's Series Seed Convertible Preferred Stock which automatically converted into warrants to acquire shares of the Issuer's common stock immediately prior to the completion of the Issuer's initial public offering on a 1-for-9.94688 basis without payment or consideration. The warrants have no expiration date. The exercise price is $1.01 per share of the issuer's common stock."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"Reflects the number of shares of the applicable series of preferred stock held by the Reporting Person on an as-converted to common stock basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Reflects the number of shares of the applicable series of preferred stock held by the Reporting Person on an as-converted to common stock basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held directly by Forbion Capital Fund III Cooperatief U.A (\"Forbion Coop\"). Forbion III Management B.V. (\"Forbion Management\") is the director of Forbion Coop. The Reporting Person serves as one of the directors of Forbion Management and disclaims beneficial ownership over all shares of the Issuer for which Forbion Management may be deemed to beneficially own, except to the extent of his pecuniary interest therein, if any."}],"balance_after":248672,"derivative":{"underlying":"Common Stock","underlying_shares":248672},"source":{"system":"sec-edgar","filing":"0001104659-18-047460","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465918047460/a4.xml","form_type":"4"}},{"id":3860624,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":95752,"kind":"person","name":"Slootweg Hugo Alexander","position":1,"cik":"0001744922","reported_name":"Slootweg Hugo Alexander","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-07-26T21:26:02.000Z","date":"2018-07-24","kind":"purchase","acquired":true,"shares":133333,"price":15,"value":1999995.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held directly by Forbion Capital Fund III Cooperatief U.A (\"Forbion Coop\"). Forbion III Management B.V. (\"Forbion Management\") is the director of Forbion Coop. The Reporting Person serves as one of the directors of Forbion Management and disclaims beneficial ownership over all shares of the Issuer for which Forbion Management may be deemed to beneficially own, except to the extent of his pecuniary interest therein, if any."}],"balance_after":4721449,"source":{"system":"sec-edgar","filing":"0001104659-18-047460","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465918047460/a4.xml","form_type":"4"}},{"id":3860623,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":95752,"kind":"person","name":"Slootweg Hugo Alexander","position":1,"cik":"0001744922","reported_name":"Slootweg Hugo Alexander","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-07-26T21:26:02.000Z","date":"2018-07-24","kind":"exercise","acquired":true,"shares":1013547,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the completion of the Issuer's initial public offering, each share of the Issuer's series seed convertible preferred stock, series A convertible preferred stock and series B convertible preferred stock (collectively, the \"Preferred Stock\") converted into shares of the Issuer's common stock on a 1-for-9.94688 basis without payment or consideration. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held directly by Forbion Capital Fund III Cooperatief U.A (\"Forbion Coop\"). Forbion III Management B.V. (\"Forbion Management\") is the director of Forbion Coop. The Reporting Person serves as one of the directors of Forbion Management and disclaims beneficial ownership over all shares of the Issuer for which Forbion Management may be deemed to beneficially own, except to the extent of his pecuniary interest therein, if any."}],"balance_after":4588116,"source":{"system":"sec-edgar","filing":"0001104659-18-047460","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465918047460/a4.xml","form_type":"4"}},{"id":3860622,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":95752,"kind":"person","name":"Slootweg Hugo Alexander","position":1,"cik":"0001744922","reported_name":"Slootweg Hugo Alexander","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-07-26T21:26:02.000Z","date":"2018-07-24","kind":"exercise","acquired":true,"shares":2579881,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the completion of the Issuer's initial public offering, each share of the Issuer's series seed convertible preferred stock, series A convertible preferred stock and series B convertible preferred stock (collectively, the \"Preferred Stock\") converted into shares of the Issuer's common stock on a 1-for-9.94688 basis without payment or consideration. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held directly by Forbion Capital Fund III Cooperatief U.A (\"Forbion Coop\"). Forbion III Management B.V. (\"Forbion Management\") is the director of Forbion Coop. The Reporting Person serves as one of the directors of Forbion Management and disclaims beneficial ownership over all shares of the Issuer for which Forbion Management may be deemed to beneficially own, except to the extent of his pecuniary interest therein, if any."}],"balance_after":3574569,"source":{"system":"sec-edgar","filing":"0001104659-18-047460","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465918047460/a4.xml","form_type":"4"}},{"id":3860621,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":95752,"kind":"person","name":"Slootweg Hugo Alexander","position":1,"cik":"0001744922","reported_name":"Slootweg Hugo Alexander","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-07-26T21:26:02.000Z","date":"2018-07-24","kind":"exercise","acquired":true,"shares":994688,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the completion of the Issuer's initial public offering, each share of the Issuer's series seed convertible preferred stock, series A convertible preferred stock and series B convertible preferred stock (collectively, the \"Preferred Stock\") converted into shares of the Issuer's common stock on a 1-for-9.94688 basis without payment or consideration. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held directly by Forbion Capital Fund III Cooperatief U.A (\"Forbion Coop\"). Forbion III Management B.V. (\"Forbion Management\") is the director of Forbion Coop. The Reporting Person serves as one of the directors of Forbion Management and disclaims beneficial ownership over all shares of the Issuer for which Forbion Management may be deemed to beneficially own, except to the extent of his pecuniary interest therein, if any."}],"balance_after":994688,"source":{"system":"sec-edgar","filing":"0001104659-18-047460","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465918047460/a4.xml","form_type":"4"}}]}